Global Nucleic Acid Amplification Test (NAAT) Market Outlook , Size, Forecasts, Demand, Competitive Analysis, Growth Factors, Key Players

SDKI Inc. published a new report on the global nucleic acid amplification test (NAAT) market. This study includes the statistical and analytical approaches needed to grow the Nucleic Acid Amplification Test (NAAT) market. The key industry insights provided in the report provide readers with better ideas about market overviews regarding existing market scenarios. In addition, the report contains a detailed discussion of current and future market trends related to market growth.

Report sample URL
https://www.sdki.jp/sample-request-111565

The Nucleic Acid Amplification Test (NAAT) market is estimated to reach US $ 6.10 billion by 2030 from a market value of US $ 3.05 billion in 2022 and is expected to grow at a CAGR of 10.4% during the 2022-2030 forecast period. It has been.

Nucleic acid amplification test (NAAT) is a biology of urine and tissues. An innovative technique used to identify specific nucleic acids, bacteria, or viruses that act as pathogens from target samples. In addition, this technique is often used for blood screening donations to reduce the risk of transfusion infections in recipients. Nucleic acid amplification tests are also an accurate detection technique used for most infectious pathogens as they help diagnose and improve patient care in high-income countries. Therefore, it is more widely adopted than traditional diagnostic techniques for treating infectious diseases such as HIV and Ebola. These factors are driving the growth of the Nucleic Acid Amplification Test (NAAT) market during the forecast period.

According to the Joint United Nations Program on HIV / AIDS (UNAIDS), about 1.7 million people were newly infected with HIV in 2019, compared to 2.8 million adults in 1998. Therefore, increasing prevalence of HIV disease worldwide will drive NAAT adoption in the coming years. In addition to infectious diseases, NAAT is widely used in many other areas such as cancer, personalized medicine, and forensic medicine. This could spur NAAT adoption and usefulness during the forecast period. In addition, increased spending or investment in the pharmaceutical and biopharmacy sectors, as well as increased demand for advanced diagnostic instruments, have contributed to the growth of the nucleic acid amplification test (NAAT) market during the forecast period.

However, the high cost of testing and the lack of skilled professionals could curb the growth of the nucleic acid amplification test (NAAT) market during the forecast period (2022-2030).

Sample URL for the report
https://www.sdki.jp/sample-request-111565

Nucleic Acid Amplification Test (NAAT) Market Segment

The Nucleic Acid Amplification Test (NAAT) market is divided by technology (target amplification system, probe amplification system, signal amplification system), application (infectious disease, cancer, etc.), and region. These segments are further subsegmented based on various factors and consist of some additional information about the market, such as the combined annual growth rate of each segment and subsegment, the market value and volume of the valuation period.

Regional Overview of the Nucleic Acid Amplification Test (NAAT) Market

North American region is the world's leading region in terms of market share. This is due to the growing government support for conducting nucleic acid amplification tests (NAATs) and the significant presence of market vendors in the region. Meanwhile, the Asia Pacific Nucleic Acid Amplification Test (NAAT) market is expected to show the highest growth rate / CAGR during the forecast period (2022-2030). Factors such as the rising prevalence of life-threatening diseases and infectious diseases and the increasing adoption of innovative diagnostic techniques in developing countries such as China and India are factors in the Nucleic Acid Amplification Test (NAAT) market in the Asia-Pacific region. Creates a favorable opportunity for growth.

These regional segments are North America (US and Canada); Asia Pacific (China, India, Japan, South Korea, Indonesia, Malaysia, Australia, New Zealand, Singapore, Other Asia Pacific); Latin America (Brazil, Mexico, Argentina, etc.) Latin America); Middle East and Africa (Israel, GCC [Saudi Arabia, Arab Emirates, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, and other Middle East and Africa) and Europe (UK, Germany, France, Italy) , Spain, Hungary, Belgium, Netherlands, Luxemburg, NORDIC, Poland, Turkey, Russia and other Europe) and more.

Key Players

Nucleic Acid Amplification Test (NAAT) Market Key players in the Nucleic Acid Amplification Test (NAAT) Market include Abbott Laboratories, Becton, Dickinson and Company, BioMérieux SA, Bio-Rad Laboratories, Inc., Grifols, SA. , F. Hoffmann-La Roche AG, Hologic, Inc., Illumina, Inc., Beckman Coulter, Inc., Siemens Healthcare GmbH and more. The study includes a detailed competitive analysis of these major companies in the nucleic acid amplification test (NAAT) market, company profiles, recent developments, and key market strategies.

Details of the survey report
https://www.sdki.jp/press-details/global-nucleic-acid-amplification-test-naat-market/343

15/F Cerulean Tower, 26-1 Sakuragaoka-cho
Tokyo, Shibuya-ku, Japan
+ 81345720790
sales@sdki.jp

SDKI Inc.'s goal is market scenarios in various countries such as Japan, China, the United States, Canada, the United Kingdom, and Germany. Is to clarify. We also focus on providing reliable research insights to clients around the world, including growth indicators, challenges, trends and competitive environments, through a diverse network of research analysts and consultants. With SDKI gaining trust and a customer base in more than 30 countries, SDKI is even more focused on expanding its foothold in other pristine economies.

This release was published on openPR.